Chakir K, Ju M M, Shevtsov S P, Golubkov V I, Skobeleva N A, Shur Y A, Zakharova F M, Lipovetskyi B M, Konstantinov V O, Denisenko A D, Gaitskhoki V S, Schwartz E I
Petersburg Nuclear Physics Institute, Russian Academy of Sciences, Gatchina, 188350, Russia.
Mol Genet Metab. 1998 Dec;65(4):311-4. doi: 10.1006/mgme.1998.2762.
Familial hypercholesterolemia (FH), a monogenic disease known to be caused by low-density lipoprotein receptor (LDLR) gene mutations, results in the development of premature atherosclerosis and coronary artery disease in affected individuals. The spectrum of LDLR gene mutations in Russia is poorly known. Using polymerase chain reaction (PCR)-single-strand conformational polymorphism (SSCP) analysis, followed by DNA sequencing, we have screened selected exons of the LDLR gene in 80 unrelated St. Petersburg FH patients for the presence of mutations. Two new LDLR gene mutations, 347delGCC and E397X, were characterized among individuals with familial hypercholesterolemia in St. Petersburg. The carriers of both mutations possessed highly elevated blood serum cholesterol. Cosegregation of E397X mutation and LDLR gene RFLP haplotypes with hyperlipidemia was demonstrated by family study. Both mutations seem to be specific to Slavic patients.
家族性高胆固醇血症(FH)是一种已知由低密度脂蛋白受体(LDLR)基因突变引起的单基因疾病,会导致受影响个体过早出现动脉粥样硬化和冠状动脉疾病。俄罗斯LDLR基因突变谱鲜为人知。我们采用聚合酶链反应(PCR)-单链构象多态性(SSCP)分析,随后进行DNA测序,在80名来自圣彼得堡的无亲缘关系的FH患者中筛查LDLR基因的选定外显子,以检测是否存在突变。在圣彼得堡的家族性高胆固醇血症患者中发现了两种新的LDLR基因突变,即347delGCC和E397X。两种突变的携带者血清胆固醇水平均显著升高。通过家系研究证实了E397X突变和LDLR基因RFLP单倍型与高脂血症的共分离。这两种突变似乎是斯拉夫患者所特有的。